Latest News of TMDX
TransMedics Group Inc (TMDX) Q3 2024 Earnings Call Highlights: Robust Revenue Growth Amid ...
The company forecasts revenue of $425 million to $445 million for the year, expecting growth of 76% to 84%. CEO Waleed Hassanein expressed confidence in the guidance, citing normalization in dynamics ...
Here's Why TransMedics Group (TMDX) Rose in Q2
Carillon Tower Advisers' Carillon Eagle Small Cap Growth Fund Q2 2024 investor letter discusses small-cap stock performance. It highlights TransMedics Group, Inc. (NASDAQ:TMDX) as a top pick, with str...
TransMedics Group, Inc. (TMDX): One of Oppenheimer's Top Stock Picks For the Next 12 Months
Oppenheimer's Favorite Stocks for the Next 12 Months includes TransMedics Group, Inc. (NASDAQ:TMDX) as a top pick. The company specializes in organ transplant services and logistics, with potential gr...
-
TransMedics (TMDX) Rallied 104% in Q2
By Yahoo! Finance | 3 months agoHeadwaters Capital Management's Q2 2024 investor letter noted a 1.3% return amid a calm market period. The fund focuses on companies with competitive advantages and strong growth potential. Notable st...
-
TransMedics Group, Inc. (NASDAQ:TMDX) About To Shift From Loss To Profit
By Yahoo! Finance | 4 months agoTransMedics Group, Inc. is a medical technology company close to reaching profitability with anticipated positive profits in 2024. Analysts predict breakeven within 12 months, but high debt levels may...